EPZM - Epizyme EPS misses by $0.08 beats on revenue February, 24 2020 06:32 AM Epizyme Inc. Epizyme (NASDAQ:EPZM): Q4 GAAP EPS of -$0.59 misses by $0.08.Revenue of $4.29M (-55.8% Y/Y) beats by $1.21M.Press ReleaseMore news on: Epizyme, Inc., Earnings news and commentary, Healthcare stocks news,